Compare
Envista Holdings Corp vs Dentsply Sirona Inc.
| Latest fiscal year | Envista Holdings Corp NVST | Dentsply Sirona Inc. XRAY |
|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 |
| Revenue | $2.72B | $3.68B |
| Revenue growth (YoY) | +8.3% | -3.0% |
| Gross margin | 54.7% | 50.0% |
| Operating margin | 7.9% | -11.5% |
| Net margin | 1.7% | -16.3% |
| Net income | $47.00M | -$598.00M |
| EPS (Diluted) | $0.28 | -$3.00 |
| Operating cash flow | $275.70M | $235.00M |
| Free cash flow | $230.40M | $104.00M |
| Cash & equivalents | $1.21B | $326.00M |
| Total assets | $5.68B | $5.43B |
| Total liabilities | n/a | $4.09B |
| Shareholders' equity | $3.11B | $1.34B |
| Return on year-end equity | 1.5% | -44.6% |
| Shares outstanding | 163.80M | 199.60M |
Revenue, most recent five fiscal years
| Fiscal year | Envista Holdings Corp | Dentsply Sirona Inc. |
|---|---|---|
| Latest | $2.72B Ended 2025-12-31 | $3.68B Ended 2025-12-31 |
| 1 year earlier | $2.51B Ended 2024-12-31 | $3.79B Ended 2024-12-31 |
| 2 years earlier | $2.57B Ended 2023-12-31 | $3.96B Ended 2023-12-31 |
| 3 years earlier | $2.57B Ended 2022-12-31 | $3.92B Ended 2022-12-31 |
| 4 years earlier | $2.51B Ended 2021-12-31 | $4.23B Ended 2021-12-31 |